ArticleBMC infectious diseases2025
Novel screening model for infectious mononucleosis in febrile pediatric patients using a 3D-DIFF scattergram.
Article in BMC infectious diseases, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
14 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundInfectious mononucleosis (IM) is an acute self-limited disease caused mainly by Epstein-Barr virus (EBV) that is prone to be missed or misdiagnosed in febrile children due to a lack of obvious clinical symptoms. Establishing a model based on blood cell parameters for identifying patients with IM is important for the subsequent diagnosis and treatment of children with fever.
methodsFrom January to December 2023, data of a total of 5511 febrile children (including 518 IM patients with primary EBV infection) were collected from Children's Hospital Zhejiang University School of Medicine. After assessing the changes in lymphoid clusters on the 3D-DIFF scatter plot and further analyzing the parameters of the scattergrams for quantifying the fluorescence signal changes in IM patients through the probability density function, eleven features were selected from among 41 blood cell parameters to construct the final Novel IM screening model (Novel IMs model).
resultsThe Novel IMs model performed well in three sets, screening IM patients with an accuracy of more than 91.92%. Compared others, the Novel IMs model had the best identification accuracy, specificity, and sensitivity and reached an area under the receiver operating characteristic (ROC) curve (AUC) in identifying IM patients of 0.96.
conclusionThis study is the first to develop a machine learning model to screening IM patients from febrile children using parameters obtained from blood cell scattergrams. This convenient and low-cost technique for initial screening of IM by hematology analysis may improve the screening coverage of the disease and further reduce misdiagnosis and underdiagnosis.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.